Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R132818-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $34.90 | |
R132818-250mg | 250mg | In stock | $68.90 | |
R132818-500mg | 500mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $156.90 | |
R132818-1g | 1g | In stock | $248.90 | |
R132818-5g | 5g | In stock | $1,117.90 |
Irreversible monoamine oxidase (MAO) inhibitor
Synonyms | 1986-47-6 | Tranylcypromine hydrochloride | 37388-05-9 | trans-2-Phenylcyclopropylamine hydrochloride | trans-2-Phenylcyclopropanamine hydrochloride | (1R,2S)-2-phenyl-cyclopropylamine hydrochloride | (1R,2S)-2-Phenylcyclopropanamine hydrochloride | (1R,2S)-2-phenylcyc |
---|---|
Specifications & Purity | ≥97% |
Biochemical and Physiological Mechanisms | Non-selective MAO-A/B inhibitor.Irreversible monoamine oxidase (MAO) inhibitor. Increases serotonergic, noradrenergic activity and augments dopamine transmission. Additionally inhibits LSD1 (BHC110), inhibiting histone demethylation (IC 50 = >50 μM). Anti |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | trans-2-Phenylcyclopropylamine hydrochloride is a non-selective MAO-A/B inhibitor. trans- 2-Phenylcyclopropylamine Hydrochloride is an inhibitor of LSD1. LSD1 specifically demethylates lysine on histones. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (1R,2S)-2-phenylcyclopropan-1-amine;hydrochloride |
---|---|
INCHI | InChI=1S/C9H11N.ClH/c10-9-6-8(9)7-4-2-1-3-5-7;/h1-5,8-9H,6,10H2;1H/t8-,9+;/m0./s1 |
InChi Key | ZPEFMSTTZXJOTM-OULXEKPRSA-N |
Canonical SMILES | C1C(C1N)C2=CC=CC=C2.Cl |
Isomeric SMILES | C1[C@H]([C@@H]1N)C2=CC=CC=C2.Cl |
WGK Germany | 3 |
PubChem CID | 2723716 |
Molecular Weight | 169.65 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2423033 | Certificate of Analysis | Mar 01, 2024 | R132818 |
L2106718 | Certificate of Analysis | Sep 19, 2023 | R132818 |
L2106731 | Certificate of Analysis | Sep 19, 2023 | R132818 |
Solubility | Soluble in water (100 mM), methanol, DMSO (50 mg/ml), ethanol, and ethyl acetate. |
---|---|
Specific Rotation[α] | [α]/D −1 to +1.0°, c = 1 in H2O |
Melt Point(°C) | 162-169 °C (lit.) |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
1. Therese Ericsson,Jesper Sundell,Angelica Torkelsson,Kurt-Jürgen Hoffmann,Michael Ashton. (2014-01-10) Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.. Xenobiotica; the fate of foreign compounds in biological systems, 44 ((7)): (615-626). [PMID:24400699] |
2. Robert Haberzettl,Heidrun Fink,Bettina Bert. (2014-05-02) The murine serotonin syndrome - evaluation of responses to 5-HT-enhancing drugs in NMRI mice.. Behavioural brain research, 277 (204-210). [PMID:24780865] |
3. Christine R Klaus,Dorothy Iwanowicz,Danielle Johnston,Carly A Campbell,Jesse J Smith,Mikel P Moyer,Robert A Copeland,Edward J Olhava,Margaret Porter Scott,Roy M Pollock,Scott R Daigle,Alejandra Raimondi. (2014-07-06) DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells.. The Journal of pharmacology and experimental therapeutics, 350 ((3)): (646-656). [PMID:24993360] |
4. Julia Dinger,Markus R Meyer,Hans H Maurer. (2014-08-12) Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.. Toxicology letters, 230 ((1)): (28-35). [PMID:25111188] |
5. Susanna Tse,Louis Leung,Sangeeta Raje,Mark Seymour,Yoko Shishikura,R Scott Obach. (2014-09-14) Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry.. Drug metabolism and disposition: the biological fate of chemicals, 42 ((12)): (2023-2032). [PMID:25217486] |
6. Yuki Ogawa,Mitsuru Irikura,Yuka Kobaru,Mayu Tomiyasu,Yoshie Kochiyama,Mamiko Uriu,Yoichi Ishitsuka,Yuki Kondo,Eiji Yukawa,Noboru Kamada,Hitoshi Ohno,Toshio Yamazaki,Tetsumi Irie. (2014-09-25) Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.. European journal of pediatrics, 174 ((4)): (509-518). [PMID:25248340] |
7. Ramakrishna Nirogi,Raghava Choudary Palacharla,Abdul Rasheed Mohammed,Arunkumar Manoharan,Ranjith Kumar Ponnamaneni,Gopinadh Bhyrapuneni. (2015-02-07) Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.. Chemico-biological interactions, 230 (9-20). [PMID:25656918] |
8. Peng Han,Dehong Gao,Wei Zhang,Suhuan Liu,Shuyu Yang,Xuejun Li. (2015-03-31) Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells.. Life sciences, 130 (103-107). [PMID:25817234] |
9. Sarah J Morse,Anderson A Butler,Robin L Davis,Ian J Soller,Farah D Lubin. (2015-04-04) Environmental enrichment reverses histone methylation changes in the aged hippocampus and restores age-related memory deficits.. Biology, 4 ((2)): (298-313). [PMID:25836028] |
10. Jennifer L Goldman,J Steven Leeder,Leon Van Haandel,Robin E Pearce. (2015-07-04) In Vitro Hepatic Oxidative Biotransformation of Trimethoprim.. Drug metabolism and disposition: the biological fate of chemicals, 43 ((9)): (1372-1380). [PMID:26138612] |
11. Kaisa A Salminen,Minna Rahnasto-Rilla,Raija Väänänen,Peter Imming,Achim Meyer,Aline Horling,Antti Poso,Tuomo Laitinen,Hannu Raunio,Maija Lahtela-Kakkonen. (2015-09-25) Time-Dependent Inhibition of CYP2C19 by Isoquinoline Alkaloids: In Vitro and In Silico Analysis.. Drug metabolism and disposition: the biological fate of chemicals, 43 ((12)): (1891-1904). [PMID:26400396] |
12. James M Hill,Debra C Quenelle,Rhonda D Cardin,Jodi L Vogel,Christian Clement,Fernando J Bravo,Timothy P Foster,Marta Bosch-Marce,Priya Raja,Jennifer S Lee,David I Bernstein,Philip R Krause,David M Knipe,Thomas M Kristie. (2014-12-05) Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes.. Science translational medicine, 6 ((265)): (265ra169-265ra169). [PMID:25473037] |